KF
IRWD icon

Krilogy Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Krilogy Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144K Buy
33,194
+2,971
+10% +$12.2K ﹤0.01% 921
2025
Q4 		$157K Buy
30,223
+15
+0% +$39 0.01% 893
2025
Q3 		$62.2K Buy
+30,208
New +$31.3K ﹤0.01% 850

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Krilogy Financial's IRWD Position: Q1 2026 in Review

Krilogy Financial increased its Ironwood Pharmaceuticals (IRWD) stake by 9.8% in Q1 2026, buying an estimated $12.2K and bringing the position to 33,194 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #921.

Krilogy Financial first reported a position in IRWD in Q3 2025 and has held it in 3 quarters since. The position peaked at $157K in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Krilogy Financial held 33,194 shares of Ironwood Pharmaceuticals worth $144K as of Q1 2026.
  • Krilogy Financial bought 2,971 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $12.2K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Krilogy Financial's portfolio in Q1 2026, its #921 holding.
  • Krilogy Financial first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Krilogy Financial's Ironwood Pharmaceuticals position peaked at $157K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.